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Pluripotent stem cells, i.e., embryonic stem (ES) and induced pluripotent stem (iPS) cells,
can indefinitely proliferate without commitment and differentiate into all cell lineages. ES
cells are derived from the inner cell mass of the preimplantation blastocyst, whereas
iPS cells are generated from somatic cells by overexpression of a few transcription
factors. Many studies have demonstrated that mouse and human iPS cells are highly
similar but not identical to their respective ES cell counterparts. The potential to
generate basically any differentiated cell types from these cells offers the possibility to
establish new models of mammalian development and to create new sources of cells
for regenerative medicine. ES cells and iPS cells also provide useful models to study
connexin expression and gap-junctional intercellular communication (GJIC) during cell
differentiation and reprogramming. In 1996, we reported connexin expression and GJIC
in mouse ES cells. Because a substantial number of papers on these subjects have
been published since our report, this Mini Review summarizes currently available data
on connexin expression and GJIC in ES cells and iPS cells during undifferentiated state,
differentiation, and reprogramming.
Keywords: connexins, gap-junctional intercellular communication, ES cells, iPS cells, differentiation,
reprogramming, pluripotency
INTRODUCTION
Gap junctions are cell–cell communicating junctions that con-
sist of multimeric proteins called connexins and mediate the
exchange of low-molecular-weight metabolites and ions between
contacting cells (Oyamada et al., 2013). Gap-junctional inter-
cellular communication (GJIC) has long been hypothesized to
play a crucial role in the maintenance of homeostasis, morpho-
genesis, cell differentiation, and growth control in multicellular
organisms. Discoveries of human genetic disorders due to muta-
tions in connexin genes and experimental data on connexin
knockout mice provide direct evidence that gap junctional inter-
cellular communication is essential for tissue functions and organ
development and that its dysfunction causes diseases. Connexin-
related signaling also involves extracellular signaling (hemichan-
nels) and non-channel intracellular signaling.
GJIC during embryonal development has been demonstrated
by using microelectrode impalements to monitor the cell-to-
cell movement of ions (ionic coupling) and by microinjection
of small-molecular-weight fluorescent dyes such as Lucifer yel-
low into a single cell and observation of the subsequent dye
spread into the surrounding cells (dye coupling) (Lo and Gilula,
1979; Kalimi and Lo, 1988, 1989). It has been revealed that in
many instances, GJIC is established within the first few cleav-
ages and results in the entire embryo becoming interconnected
as a syncytium. As development progresses, however, dye cou-
pling delineates boundaries defining restrictions in GJIC that
effectively segregate the developing embryo or tissue into a
number of “communication compartment” domains. Thus, cells
lying within a communication compartment are well coupled,
exhibiting both ionic and dye coupling, whereas there is little or
no coupling between cells situated across a compartment border.
Such restriction of GJIC and the segregation of cells into commu-
nication compartment domains are almost always associated with
embryogenesis and development.
Pluripotent stem cells, which include embryonic stem (ES)
cells and induced pluripotent stem (iPS) cells, possess the ability
to proliferate indefinitely without commitment in vitro and also
differentiate into all cell lineages belonging to the three embry-
onic germ layers (Evans and Kaufman, 1981; Thomson et al.,
1998; Takahashi and Yamanaka, 2006; Takahashi et al., 2007).
ES cells are derived from the inner cell mass of the preimplan-
tation blastocyst, whereas iPS cells are generated from many
different types of somatic cells by overexpression of only a few
pluripontency-related transcription factors. Many studies have
demonstrated that mouse and human iPS cells are highly sim-
ilar but not identical to their respective ES cell counterparts
morphologically, functionally, and molecularly at the level of
transcription and genome-wide distribution of chromatin modi-
fication. The potential to generate basically any differentiated cell
types from ES cells and iPS cells offers the possibility to estab-
lish new models of mammalian development and to create new
sources of cells for regenerative medicine (Robinton and Daley,
2012).
The in vitro differentiation system using ES cells and iPS cells
also provides a useful model to study connexin expression and
GJIC during the early stage of cell differentiation (Wong et al.,
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2008; Sharovskaya, 2011). In addition, the importance of under-
standing the regulation of connexin expression in differentiating
pluripotent cells is recognized in regenerative medicine.
In 1996, we first reported the expression of connexin genes
and GJIC during in vitro cardiomyocyte differentiation of
mouse ES cells (Oyamada et al., 1996). Because a substan-
tial number of papers on these subjects have been published
since our first report, this Mini Review summarizes currently
available data on connexin expression and GJIC in ES cells
and iPS cells during undifferentiated state, differentiation, and
reprogramming.
QUESTIONS ABOUT CONNEXIN EXPRESSION AND
GAP-JUNCTIONAL INTERCELLULAR COMMUNICATION IN
ES/iPS CELLS
Main questions about connexin expression and GJIC in ES/iPS
cells that have been addressed thus far can be summarized as
below:
1. What kinds of connexins are expressed in undifferentiated
ES/iPS cells?
2. To what extent do undifferentiated ES/iPS cells communicate
with each other via gap junctions?
3. What changes in connexin expression and GJIC occur during
differentiation of ES/iPS cells?
4. What roles do connexin expression and/or GJIC play in main-
tenance of pluripotency in ES/iPS cells?
5. What changes in connexin expression and GJIC occur during
induction of pluripotency in somatic cells (reprogramming)?
6. What roles do connexin expression and/or GJIC play in
reprogramming?
CURRENTLY AVAILABLE DATA ON CONNEXIN EXPRESSION
AND GAP-JUNCTIONAL COMMUNICATION IN ES CELLS
Table 1 summarizes results of published papers concerning con-
nexin expression and GJIC in ES cells.
CONNEXIN EXPRESSION AND GAP-JUNCTIONAL
INTERCELLULAR COMMUNICATION IN iPS CELLS
Table 2 summarizes results of published papers concerning con-
nexin expression and GJIC in iPS cells.
Using human iPS cells, Sharovskaya et al. (2012) reported
that GJIC is re-established during reprogramming to pluripo-
tency: GJIC in incompletely reprogrammed cells was markedly
decreased compared with that in the parental somatic cells, but
GJIC in completely reprogrammed cells exceeded that in the
parental somatic cells and was comparable to that in human ES
cells. They drew an analogy between dramatic reduction of GJIC
among the cells undergoing early reprogramming and weak GJIC
or lack thereof among epithelial stem cells, such as keratinocyte
stem cells, breast epithelial, and neural-glial stem cells, suggesting
that changes in GJIC during early reprogramming might be asso-
ciated with mesenchymal-to-epithelial transition (MET). They
also showed that the opposite process of cell differentiation from
the pluripotent state leads to the disruption of GJIC between
pluripotent and differentiated cell subsets. However, GJIC is
subsequently re-established de novo within each differentiated
cell type in vitro, forming communication compartments within
a histotype. Human iPS cells they utilized were derived from
human umbilical vein endothelial cells (HUVECs) by lentiviral
transfection with four transcription factors: KLF4, OCT4, SOX2,
and C-MYC. To evaluate changes in GJIC during late stages of
reprogramming, incompletely reprogrammed endo-iPSC10 cells
at passage 6 and completely reprogrammed cells of the same line
at passage 26 were studied. Incompletely reprogrammed iPS cells
were characterized by residual expression of endothelial-specific
genes including Cx37 and reduced expression of pluripotency-
related genes. In addition, they compared expression of connexins
in HUVEC, endo-iPS-10, 12, and human ES cells and found that
only Cx37 and Cx43 expression varied significantly in the exam-
ined cell types. In incompletely reprogrammed iPS cells, Cx37 and
Cx43 were expressed at the level similar to HUVEC. In faithfully
reprogrammed iPS cells, cells lacked characteristics of parental
HUVEC Cx37 expression, whereas Cx43 expression increased
three- to five-fold.
Ke et al. (2013) demonstrated that Cx43 is specifically and
highly enriched in undifferentiated human iPS cell lines during
and after the reprogramming process. They also showed that iPS
cells display functional GJIC and that Cx43 expression is gradu-
ally upregulated (∼4.5-fold increase) during the reprogramming
process. They observed that the Cx43 protein level increased
gradually along with the expression of the pluripotency marker
NANOG. Because Cx43 has been identified as a downstream tar-
get of the key pluripotency transcription factors OCT4, SOX2 and
NANOG (Boyer et al., 2005), Cx43 expression might be upregu-
lated by the key factors during reprogramming. They also found
that the ectopic expression of Cx43 enhances the reprogram-
ming efficiency (∼3-fold increase), whereas the knockdown of
endogenous Cx43 expression by RNAi reduces the efficiency, pos-
sibly by affecting the MET process, as reported by changes in
E-cadherin expression. In addition, they showed that pharma-
cological GJIC inhibitors, CBX, 18-a-GA and the Cx43 mimetic
peptide GAP27, did not affect the efficiency of iPS cell genera-
tion, suggesting that the effect of Cx43 on the efficiency of iPS
cell generation may be attributed to the Cx43 protein itself but
not to the function of GJIC, i.e., through a GJIC-independent
pathway.
Taken together, these results suggest that Cx43 may represent a
pluripotency marker of iPS cells and may play an important role
in the reprogramming process.
Lundy et al. (2013) recently have developed a cell culture
protocol capable of generating and maintaining highly purified
human ES cell- and iPS cell-derived cardiomyocytes for several
months in vitro. They have shown that these human ES cell-
and iPS cell-derived cardiomyocytes are capable of maturing to
a phenotype that more closely resembles adult cardiomyocytes
in both structure and function. A robust induction of key car-
diac structural markers including Cx43 has been demonstrated
in late-stage ES cell- and iPS cell-derived cardiomyocytes. These
findings suggest that ES cell- and iPS cell-derived cardiomyocytes
are capable of slowly maturing to more closely resemble the phe-
notype of adult cardiomyocytes and may eventually possess the
potential to regenerate the lost myocardium with robust de novo
force-producing tissue.
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CONCLUSIONS: CURRENT ANSWERS TO THE QUESTIONS
ON CONNEXIN EXPRESSION AND GAP-JUNCTIONAL
INTERCELLULAR COMMUNICATION IN ES/iPS CELLS
It seems reasonable to conclude that mRNAs encoding almost
all of the connexins are expressed in ES/iPS cells. At pro-
tein level, however, expression of only a few connexins, such
as Cx43, Cx45, Cx31, and Cx40, has been confirmed. Many
studies have shown that undifferentiated ES/iPS cells commu-
nicate with each other via gap junctions at a high level. Several
studies using Cx43 RNAi demonstrated that Cx43 contributes
substantially to a high level of GJIC in undifferentiated ES/iPS
cells.
Concerning changes in connexin expression and GJIC dur-
ing differentiation of ES/iPS cells, it has been shown that
expression of tissue-related connexins, such as Cx40, Cx43,
Cx45, and Cx37 in the cardiomyocyte, is upregulated and
that GJIC between pluripotent and differentiated cells is dis-
rupted, resulting in formation of “communication compart-
ments.” Regarding changes in connexin expression and GJIC
during induction of pluripotency in somatic cells, the studies
mentioned here have demonstrated that GJIC is re-established
and Cx43 expression is upregulated during reprogramming to
pluripotency.
Cx43-mediated GJIC has been shown to play an important
role in maintenance of pluripotency. In fact, pharmacological
blockers of GJIC and Cx43 downregulation by siRNA have been
shown to induce a loss of their pluripotent state in mouse ES
cells (Todorova et al., 2008). Cx43 has also been shown to play an
important role in reprogramming, possibly by GJIC-independent
mechanism including effects on the MET process (Sharovskaya
et al., 2012; Ke et al., 2013).
Because the literature on connexin expression and GJIC in iPS
cells is limited, it is difficult to conclude whether there are dif-
ferences between ES and iPS cells at present. However, available
data suggest that human ES and iPS cells share a similar feature
concerning expression and function of connexins.
Although important roles of connexin expression and/or GJIC
in ES/iPS cells can be currently perceived, many critical ques-
tions including precise mechanisms by which connexin expres-
sion influences pluripotency and reprogramming remain to be
clarified.
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